Envoy Medical Announces 1-for-10 Reverse Stock Split to Maintain Nasdaq Compliance

Envoy Medical (COCH) has announced a 1-for-10 reverse stock split, scheduled to take effect on October 26, 2026. The primary objective of this corporate action is to ensure the company remains in compliance with Nasdaq's minimum $1.00 bid price requirement and to improve its appeal to institutional investors. Following the announcement, COCH shares experienced an 8% decline in premarket trading. Recent financial data for the company shows a GAAP EPS of -$0.07 and revenue of $0.05 million, highlighting the ongoing fiscal challenges driving the need for the split.

6 articles from 3 sources · updated

Coverage